• Position Paper of the Fair Trade Cannabis Working Group in the Caribbean

    The Position Paper "For inclusive business models, well designed laws and fair(er) trade options for small-scale traditional cannabis farmers” produced by The Fair(er) Trade Cannabis Working Group aims to contribute to the debate on finding sustainable and realistic solutions to the challenges posed by the developing cannabis industry, with a special focus on traditional and small scale farmers.

    READ MORE...
  • Rescheduling cannabis at the UN level

    Here’s all you need to know about the WHO’s recommendations to reschedule cannabis and cannabis-related substances
    Thursday, October 15, 2020

    Following its first-ever critical review of cannabis, in January 2019 the World Health Organization's Expert Committee on Drug Dependence (ECDD) issued recommendations to reschedule cannabis and cannabis-related substances. The Commission on Narcotic Drugs (CND) are set to vote on these recommendations in December 2020. Eagerly awaited, the ECDD recommendations contain some positive points, such as acknowledging the medicinal usefulness of cannabis by removing it from Schedule IV of the 1961 Single Convention on Narcotics Drugs and clarifying that cannabidiol (CBD) is not under international control. But the ECDD recommendations also reveal problematic underlying evaluation methods and scheduling procedures along with a very questionable rationale for keeping cannabis in Schedule I. Read more ...

  • A World with Drugs: Legal Regulation through a Development Lens

    Webinar Series

    Drugs are a development issue. Let’s stop pretending that they’re not. The so-called ‘war on drugs’ has been undermining progress towards development goals for decades. It has fuelled violence and conflict, undermined democracy, and driven poverty, inequality and poor health worldwide. The shift towards the legal regulation of drugs provides a chance to repair the harms of the past – and create a fairer, more just world for the future. Now is the time to build a new approach to drugs that prioritises, promotes and protects health and well-being, helps address poverty and inequality, and contributes to achieving the Sustainable Development Goals (SDGs). Join us for this ground-breaking 8-part webinar series

  • Cannabis Regulation and Development

    Fair(er) Trade Options for Emerging Legal Markets
    David Bewley-Taylor, Martin Jelsma, and Sylvia Kay
    Drug Policies and Development: Conflict and Coexistence
    12th volume of International Development Policy, August 2020

    Significant policy shifts have led to an unprecedented boom in medical cannabis markets, while a growing number of countries are moving towards the legal regulation of adult non-medical use. This trend is likely to bring a range of benefits. Yet there are growing concerns over the many for-profit cannabis companies from the global North that are aggressively competing to capture the licit spaces now opening in the multibillion-dollar global cannabis market. This threatens to push small-scale traditional farmers from the global South out of the emerging legal markets.

    Read the chapter

    READ MORE...
  • Smokable cocaine markets in Latin America and the Caribbean

    A call for a sustainable policy response
    Ernesto Cortés Amador & Pien Metaal
    Transnational Institute (TNI)
    March 2020

    The smokable cocaine market was established decades ago, and is definitely not a new phenomenon. Rather than disappear, it is undergoing a slow expansion: from constituting a rather localized and isolated habit in the Andean region in the 1970s, its reach has extended in all directions, throughout North and South-America, including the Caribbean and Central American regions. Societies in the Americas have coexisted with smokable cocaines for over four decades, but - surprisingly - there is a dearth of research on the development of the market, or much first-hand evidence of how this substance is actually commercialized and used by millions of people in the region.

    application pdfDownload the report (PDF)

    READ MORE...
  • Human Rights and drug policy

    Drug control should respect human rights

    The Transnational Institute (TNI) has always believed in the need to find global answers to global problems, been a strong defender of multilateralism and an advocate of a well-functioning United Nations which stands as the guarantor of universal human rights. On the drugs question, our position is straightforward: drug control should respect human rights. An accessible but comprehensive primer on why TNI believes that human rights must be at the heart of any debate on drug control.

    READ MORE...
  • The UN Drug Control Conventions

    A primer

    For more than ten years, TNI’s Drugs & Democracy programme has been studying the UN drug control conventions and the institutional architecture of the UN drug control regime. As we approach the 2016 UNGASS, this primer is a tool to better understand the role of these conventions, the scope and limits of their flexibility, the mandates they established for the CND, the INCB and the WHO, and the various options for treaty reform. (PDF version: Primer: The UN Drug Control Conventions)

    READ MORE...
  • UN Common Position on drug policy

    Consolidating system-wide coherence
    Martin Jelsma
    Briefing paper
    December 2019

    In November 2018, the UN System CEB adopted the ‘UN system common position supporting the implementation of the international drug control policy through effective inter-agency collaboration’, expressing the shared drug policy principles of all UN organisations and committing them to speak with one voice. The CEB is the highest-level coordination forum of the UN system, convening biannual meetings of the heads of all UN agencies, programmes and related institutions, chaired by the UN Secretary General. 

    application pdfDownload the briefing (PDF)

    READ MORE...
  • Regulating Drugs: Resolving Conflicts with the UN Drug Control Treaty System

    John Walsh & Martin Jelsma
    Journal of Illicit Economies and Development, 1(3), pp.266–271
    November 2019

    There are good reasons to legally regulate drugs markets, rather than persist with efforts to ban all non-medical uses of psychoactive substances. Regulated cannabis and coca markets are already a reality in several countries, with more likely to follow. But ignoring or denying that such policy shifts contravene certain obligations under the UN drug control treaties is untenable and risks undermining basic principles of international law. States enacting cannabis regulation must find a way to align their reforms with their international obligations.

    Read the full article ...

    READ MORE...
  • The Challenges of Medicinal Cannabis in Colombia

    A look at small - and medium - scale growers
    Nicolás Martínez Rivera
    Drug Policy Briefing Nr. 52
    September 2019

    In July 2016, the Colombian government enacted Law 1787, which regulates the use of medicinal cannabis and its trade in the country. With this decision and a series of subsequent resolutions, Colombia joined the more than a dozen countries that have put into practice different types of regulation to explore the advantages of this plant as an alternative pharmaceutical. Even though the law stipulates that 10 per cent of production should come from small- and medium- scale growers, the reality is that most of the business has been dominated by large local and foreign investors.

    application pdfDownload the briefing (PDF)

    READ MORE...

Page 2 of 5